ArticleClinical immunology (Orlando, Fla.)2021
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome.
Article in Clinical immunology (Orlando, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Complex management of GS (Good's syndrome) with persistent COVID-19 infection and polymicrobial infections: A case report.Heliyon · 2025Article
- Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature.Immunologic research · 2024Review
- Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review.Clinical case reports · 2024Article
- Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.Immunological reviews · 2024Review
- Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient: a case report.BMC infectious diseases · 2024Article
- COVID-19 and Inborn Errors of Immunity.Physiology (Bethesda, Md.) · 2022Review
- [Patient with Good's syndrome and COVID-19. Report of a clinical case].Revista medica del Instituto Mexicano del Seguro Social · 2022Article
- Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.Expert review of vaccines · 2022Article
- Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.Clinical immunology (Orlando, Fla.) · 2022Article
- COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency.Clinical immunology communications · 2021Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.